Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
This document provides an update on an ongoing Phase 1/2 clinical trial evaluating pomalidomide, dexamethasone, and pegylated liposomal doxo…
-
CLINICAL_TRIALS research · 2016-02-29Clinical Trial Update: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Update on a clinical trial evaluating umbilical cord blood stem cell transplant for leukemia, lymphoma, and other hematologic conditions. Th…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 [Phase 1, Phase 2]
This clinical trial update describes CART-138, a CAR-T cell therapy, being studied in Phase 1/2 for chemotherapy-refractory multiple myeloma…
-
CLINICAL_TRIALS research · 2016-01-07Clinical Trial Update: The Molecular Characterization of Multiple Myeloma at Relapse
The trial update reports completed efforts to characterize the molecular features of multiple myeloma at relapse, focusing on biomarker and …
-
CLINICAL_TRIALS research · 2016-01-05Clinical Trial Update: Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
This clinical trial update describes an expanded treatment protocol using panobinostat in combination with bortezomib and dexamethasone for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-08Clinical Trial Update: Microdose Study of Melphalan, Bortezomib and Dexamethasone [EARLY_Phase 1]
An early-phase clinical trial update evaluating a microdose combination of melphalan, bortezomib, and dexamethasone for multiple myeloma.
-
CLINICAL_TRIALS research · 2015-12-08Clinical Trial Update: Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating clarithromycin or sulfamethoxazole/trimethoprim versus observation in newly diagnosed multiple myeloma to address i…
-
CLINICAL_TRIALS research · 2015-10-26Clinical Trial Update: UARK 2009-32 Compassionate Use Study of Carfilzomib
Compassionate-use study of carfilzomib for multiple myeloma is no longer available (status NO_LONGER_AVAILABLE).
-
CLINICAL_TRIALS research · 2015-09-04Clinical Trial Update: Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
Expanded-access single-patient program for the monoclonal antibody elotuzumab in a relapsed/refractory multiple myeloma patient (R-A); the p…
-
CLINICAL_TRIALS research · 2015-08-18Clinical Trial Update: Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China [Phase 1, Phase 2]
Clinical trial comparing subcutaneous versus intravenous administration of bortezomib in multiple myeloma patients in China across Phase 1 a…
-
CLINICAL_TRIALS research · 2015-07-27Clinical Trial Update: Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma [Phase 1, Phase 2]
A clinical trial update on total marrow irradiation with autologous stem cell transplantation for relapsed or refractory multiple myeloma (P…
-
CLINICAL_TRIALS research · 2015-03-03Clinical Trial Update: Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma
A retrospective review of engraftment syndrome following autologous stem cell transplantation in patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2015-03-03Clinical Trial Update: Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
An observational study update evaluating whether procalcitonin testing could impact the care of stem cell transplant recipients. The study, …
-
CLINICAL_TRIALS research · 2015-01-13Clinical Trial Update: CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma [Phase 3]
A Phase 3 clinical trial is evaluating a CDD-based regimen with Bortezomib versus CDD alone in relapsed or refractory multiple myeloma with …
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial update of vismodegib after stem cell transplant in high-risk or relapsed multiple myeloma; the study status is completed.
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating mesenchymal stromal cells with cyclophosphamide for prophylaxis of acute graft-versus-host disease in pa…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating autologous dendritic cell vaccine therapy in patients with relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2014-04-28Clinical Trial Update: Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
An observational study evaluating the effects of intravenous bortezomib on osteoblast activity in patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS research · 2014-03-05Clinical Trial Update: Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors
Clinical trial update examining how levels of physical activity relate to fatigue and quality of life in multiple myeloma survivors. The sta…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial update evaluating bortezomib plus dexamethasone for relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating a combination of liposomal doxorubicin, melphalan, and bortezomib in…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
This ClinicalTrials.gov entry reports a Phase 2 trial evaluating the combination of chemotherapy and peripheral stem cell transplantation in…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [Phase 2]
Phase 2 clinical trial evaluating chemotherapy followed by donor bone marrow or peripheral stem cell transplantation in patients with hemato…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …